3D bioprinted organ-on-chips

Placeholder

Publication Date

2023

Advisor

Institution Author

Taşoğlu, Savaş
Birtek, Mehmet Tuğrul
Sarabi, Misagh Rezapour
Dabbagh, Sajjad Rahmani

Co-Authors

Mustafaoglu, Nur
Zhang, Yu Shrike

Journal Title

Journal ISSN

Volume Title

Publisher:

John Wiley and Sons Inc

Type

Review
View PlumX Details

Abstract

Organ-on-a-chip (OOC) platforms recapitulate human in vivo-like conditions more realistically compared to many animal models and conventional two-dimensional cell cultures. OOC setups benefit from continuous perfusion of cell cultures through microfluidic channels, which promotes cell viability and activities. Moreover, microfluidic chips allow the integration of biosensors for real-time monitoring and analysis of cell interactions and responses to administered drugs. Three-dimensional (3D) bioprinting enables the fabrication of multicell OOC platforms with sophisticated 3D structures that more closely mimic human tissues. 3D-bioprinted OOC platforms are promising tools for understanding the functions of organs, disruptive influences of diseases on organ functionality, and screening the efficacy as well as toxicity of drugs on organs. Here, common 3D bioprinting techniques, advantages, and limitations of each method are reviewed. Additionally, recent advances, applications, and potentials of 3D-bioprinted OOC platforms for emulating various human organs are presented. Last, current challenges and future perspectives of OOC platforms are discussed. © 2022 The Authors. Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

Description

Subject

Electrical and electronics engineering

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note